Aug 1, 1989

The value of hydrostatic balloon dilatation with adjuvant pentosan polysulfate medication in therapy of chronic interstitial cystitis

Helvetica chirurgica acta
M BeerE Schmiedt

Abstract

Twenty-one female patients suffering from interstitial cystitis were treated by oral medication of pentosane-polysulfates (200 mg/6 months). In cases with a capacity below 150 ml (n = 6) a distension therapy of bladder was performed simultaneously. The combined therapy showed good therapeutic effects for 1-2 years defined by the increase of voiding volumina and decrease of nycturia and pains. Medication of pentosane-polysulfates alone was of lower therapeutic value. Concerning urodynamic investigations we found an increase of capacity while the quality of bladder compliance did not change. We recommend these conservative therapies as an experimental alternative therapy before bladder augmentation.

  • References
  • Citations

References

  • We're still populating references for this paper, please check back later.
  • References
  • Citations

Citations

  • This paper may not have been cited yet.

Mentioned in this Paper

Urination
Catheterization
Neoplasm of Uncertain or Unknown Behavior of Bladder
Immunologic Adjuvants
Adjuvant
Alternative Medicine
Pathological Dilatation
Carcinoma in Situ of Bladder
Pentosan Polysulfate
Bladder Tissue

About this Paper

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.